Optogenerapy

Optogenerapy is a @EU_H2020 project that aims to develop innovative bio-electronic implants to improve the quality of life of patients with #MultipleSclerosis

[Optogenerapy @Optogenerapy_EU]

The #Optogenerapy project has ended!

Follow project partners @Eurecat_news @geneXplain @NormasUNE @neosurgery @AseOpticsEu @ETH_en @p_lodz_pl @ultrasion @Inserm @bostonsci @ESHPM_EUR for the latest advanced on #optoelectronics plastic materials, medical devices and more

[Eurecat @Eurecat_news]

Els implants biolectrònics desenvolupants en el projecte @Optogenerapy_EU per teràpia de l'#Esclerosi participen en la categoria Public-funded dels Public Choice Award de la @OEAonline #OEAcompetition 2021 #printedelectronics

Vota per aquesta recerca! https://t.co/MC6T5SyODr

[Optogenerapy @Optogenerapy_EU]

Cast your vote for #Optogenerapy biophotonic cell based implant, participating in the #OEAcompetition Public Choice Award

Voting open until tomorrow!

➡️https://t.co/7yaAB4dDRr

[Optogenerapy @Optogenerapy_EU]

#Optogenerapy bioelectronic implant for #MS is participating in the public-funded European project category of #OEAcompetition @LOPECMunich
@OEAonline #PrintedElectronics

VOTE FOR IT!➡️https://t.co/mIKQLrJ5Xx

[Cristina Casellas 🎗 @ccasellascoll]

This year @Optogenerapy_EU bioelectronic implant participates in the public-funded European project category.Take a look at the 3 categories and participate in voting for one of the all amazing demos in the Public Choice Award @OEAonline #OEAcompetition 2021 #printedelectronics

[Optogenerapy @Optogenerapy_EU]

[🎥VIDEO #Optogenerapy project] Learn how we developed the first subcutaneous biophotonic implant using optogenetic technology to deliver doses of therapeutic proteins to patients with #MultipleSclerosis

https://t.co/2vRV5fPOg6

[Eurecat @Eurecat_news]

#Eurecat-coordinated @Optogenerapy_EU project published in Results in Brief @CORDIS_EU
website. A new approach for treating #MultipleSclerosis using #optogenetics to reduce side effects and increase patients’ quality of life.

[Horizon Europe 🇪🇺 @HorizonEU]

#DYK that 60% of #MultipleSclerosis patients will be unable to walk unassisted 20 years after the disease’s onset?
#EUfunded @Optogenerapy_EU is exploring the use of optogenetics as a potential new way of treating MS 👇

https://t.co/AImIB649yY
#EUHealthResearch #InvestEUResearch

[Irene Norstedt @IreneNorstedt]

#DYK that 60% of #MultipleSclerosis patients will be unable to walk unassisted 20 years after the disease’s onset?

Read how #EUfunded @Optogenerapy_EU is exploring the use of optogenetics as a potential new way of treating MS 👉https://t.co/3OgCbonmvp #EUHealthResearch

[Optogenerapy @Optogenerapy_EU]

When developing Advanced Therapy Medicinal Products #ATMP such as the #Optogenerapy medical implant, both regulatory and #standardisation paths are key for an industrialisable and safe solution for #MultipleSclerosis patients

[CEN and CENELEC @Standards4EU]

Nominated by our Spanish member @NormasUNE is Joan GUASCH @joguco. Read more about his achievements: https://t.co/2cVjAWbXzC
@Eurecat_news
#standardsplusinnovation

[Eurecat @Eurecat_news]

#Eurecat-coordinated @Optogenerapy_EU project published in Results in Brief @CORDIS_EU website. A new approach for treating #MultipleSclerosis using #optogenetics to reduce side effects and increase patients’ quality of life

https://t.co/jHt1fcuMe0

[Optogenerapy @Optogenerapy_EU]

#Optogenerapy project results featured in
@CORDIS_EU Results in Brief as a new approach for treating #MultipleSclerosis exploring the use of #optogenetics

➡️https://t.co/A4ZzjgyKMo

[Joan Guasch @joguco]

Saving costs to public healthcare systems by integrating biocompatible polymers, flexible electronics and novel manufacturing technologies to produce advanced therapeutics medicinals products. @optogenerapy_EU https://t.co/Frzq9WOEee @Eurecat_news

[Optogenerapy @Optogenerapy_EU]

#Optogenerapy project know-how on micro-manufacturing of #MedicalDevices has been offered for the industrialisation of advanced point of care diagnostic devices being developed by a #CSIC institute in Barcelona
#StrongerTogether #UnitedAgainstCoronavirus

[UNE Asociación Española de Normalización @NormasUNE]

Participamos en la reunión final de @Optogenerapy_EU. Proyecto @EU_H2020 que ha desarrollado novedoso implante para el tratamiento de pacientes con esclerosis múltiple. Puedes ver la contribución al proyecto
https://t.co/m39bGcVQtM…
#MultipleSclerosis
#StandardsPlusInnovation

[Optogenerapy @Optogenerapy_EU]

During #Optogenerapy project, @ESHPM_EUR has carried out a literature review on #MS patients treatment preferences and produced a cost-effectiveness analysis assess the impact that the project's implant can have on health outcomes and health-care costs.

https://t.co/kVSK4KFJd9

[Optogenerapy @Optogenerapy_EU]

#Standardization is a powerful tool to increase the impact of #H2020 projects.

Learn more about standardization and what was done in #Optogenerapy project by @NormasUNE
https://t.co/kXIElSlA2C

[Optogenerapy @Optogenerapy_EU]

@AseOpticsEU role in #Optogenerapy project was the development of the optical design responsible to propagate the light in the cell chamber.

Find out the challenges encountered and how they overcome them

https://t.co/RwY17cKE86

[Optogenerapy @Optogenerapy_EU]

The Lodz University Technology has contributed to the project by selecting the most suitable #sterilization techniques and developing biocompatibility tests.

Know more about it in this video! 👇 @p_lodz_pl
https://t.co/MODvhKmbLy

[Optogenerapy @Optogenerapy_EU]

Take a minute to discover the role of @ultrasion in the #Optogenerapy project.

Watch the video here! 👇

https://t.co/9QEDlH1psP